Beyond the Scale: The History and Science of Body Mass Index
For decades, the Body Mass Index (BMI) has served as the primary medical screening tool to categorize individuals as underweight, normal weight, overweight, or obese. Originally developed in the 19th century by the Belgian statistician Adolphe Quetelet, it was known as the Quetelet Index before being renamed the Body Mass Index in 1972 by researcher Ancel Keys. Quetelet developed the index not as a medical diagnostic tool for individuals, but as a statistical method to describe the characteristics of the average man in a population.
Under the hood, BMI is a surrogate measure of body fatness rather than a direct measurement. It measures the relationship between your overall weight and height, assuming that as weight increases relative to height, body fat increases in proportion. While this assumption holds true for large population studies, it fails to differentiate between fat tissue and fat-free tissue (such as skeletal muscle, bone density, and water volume). Consequently, two individuals with identical heights and weights will have the exact same BMI, even if one is a professional bodybuilder with 8% body fat and the other is sedentary with 35% body fat.
Despite these limitations, BMI remains highly valued in clinical epidemiology. It is a fast, cost-free, and reproducible screening index that correlates strongly with long-term cardiovascular risks, type 2 diabetes incidence, and metabolic syndrome. However, to understand personal health status fully, clinicians now recommend combining BMI with measurements of waist circumference and body fat percentage to identify cases of normal-weight obesity—a condition where an individual has a normal weight but high levels of visceral fat, putting them at significant metabolic risk.